<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font15">for </span>
   <span class="font14">with </span>
   <span class="font13">that </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">against </span>
   <span class="font12">viral </span>
   <span class="font12">The </span>
   <span class="font12">are </span>
   <span class="font11">COVID- </span>
   <span class="font11">was </span>
   <span class="font11">antiviral </span>
   <span class="font11">drug </span>
   <span class="font11">drugs </span>
   <span class="font11">its </span>
   <span class="font11">clinical </span>
   <span class="font11">virus </span>
   <span class="font11">patients </span>
   <span class="font11">which </span>
   <span class="font11">were </span>
   <span class="font11">can </span>
   <span class="font11">treatment </span>
   <span class="font11">from </span>
   <span class="font11">also </span>
   <span class="font11">such </span>
   <span class="font11">coronavirus </span>
   <span class="font11">activity </span>
   <span class="font11">has </span>
   <span class="font10">al. </span>
   <span class="font10">this </span>
   <span class="font10">potential </span>
   <span class="font10">therapeutic </span>
   <span class="font10">protein </span>
   <span class="font10">other </span>
   <span class="font10">in-vitro </span>
   <span class="font10">respiratory </span>
   <span class="font10">between </span>
   <span class="font10">new </span>
   <span class="font10">used </span>
   <span class="font10">RNA </span>
   <span class="font10">promising </span>
   <span class="font10">studies </span>
   <span class="font10">This </span>
   <span class="font10">human </span>
   <span class="font10">have </span>
   <span class="font10">binding </span>
   <span class="font10">replication </span>
   <span class="font10">(Fig. </span>
   <span class="font10">into </span>
   <span class="font10">results </span>
   <span class="font10">been </span>
   <span class="font10">efficacy </span>
   <span class="font10">treat </span>
   <span class="font10">after </span>
   <span class="font10">several </span>
   <span class="font10">their </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">conducted </span>
   <span class="font10">inhibitor </span>
   <span class="font10">mechanism </span>
   <span class="font10">effects </span>
   <span class="font10">host </span>
   <span class="font10">inhibition </span>
   <span class="font10">through </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Med </span>
   <span class="font10">cell </span>
   <span class="font10">different </span>
   <span class="font10">due </span>
   <span class="font10">one </span>
   <span class="font10">study </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">disease </span>
   <span class="font10">these </span>
   <span class="font10">{background </span>
   <span class="font10">(); </span>
   <span class="font10">Res </span>
   <span class="font10">action </span>
   <span class="font10">both </span>
   <span class="font10">derivatives </span>
   <span class="font10">infected </span>
   <span class="font10">not </span>
   <span class="font10">protease </span>
   <span class="font10">severe </span>
   <span class="font10">inhibits </span>
   <span class="font10">trials </span>
   <span class="font10">first </span>
   <span class="font10">novel </span>
   <span class="font10">possible </span>
   <span class="font10">use </span>
   <span class="font10">including </span>
   <span class="font10">in-silico </span>
   <span class="font10">target </span>
   <span class="font10">therapy </span>
   <span class="font10">Therefore, </span>
   <span class="font10">acute </span>
   <span class="font10">data </span>
   <span class="font10">infection </span>
   <span class="font10">molecular </span>
   <span class="font10">proteins </span>
   <span class="font10">repurposing </span>
   <span class="font10">two </span>
   <span class="font10">combination </span>
   <span class="font10">more </span>
   <span class="font10">related </span>
   <span class="font10">showed </span>
   <span class="font10">targets </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">enzyme </span>
   <span class="font10">margin </span>
   <span class="font10">necessary </span>
   <span class="font10">syndrome </span>
   <span class="font10">ACE </span>
   <span class="font10">active </span>
   <span class="font10">cells </span>
   <span class="font10">combined </span>
   <span class="font10">factor </span>
   <span class="font10">inhibitors </span>
   <span class="font10">safety </span>
   <span class="font10">{border-style </span>
   <span class="font10">CLpro </span>
   <span class="font10">COVID-: </span>
   <span class="font10">These </span>
   <span class="font10">adverse </span>
   <span class="font10">but </span>
   <span class="font10">development </span>
   <span class="font10">entry </span>
   <span class="font10">important </span>
   <span class="font10">inhibiting </span>
   <span class="font10">ivermectin </span>
   <span class="font10">receptor </span>
   <span class="font10">ribavirin </span>
   <span class="font10">some </span>
   <span class="font10">HCQ </span>
   <span class="font10">inhibit </span>
   <span class="font10">kinase </span>
   <span class="font10">px;} </span>
   <span class="font10">suggested </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">Engl </span>
   <span class="font10">RDV </span>
   <span class="font10">all </span>
   <span class="font10">approved </span>
   <span class="font10">biological </span>
   <span class="font10">bonds </span>
   <span class="font10">docking </span>
   <span class="font10">effect </span>
   <span class="font10">form </span>
   <span class="font10">investigations </span>
   <span class="font10">spike </span>
   <span class="font10">synthesis </span>
   <span class="font10">than </span>
   <span class="font10">anti-SARS-CoV- </span>
   <span class="font10">authors </span>
   <span class="font10">immune </span>
   <span class="font10">pyrimidine </span>
   <span class="font10">structure </span>
   <span class="font10">structures </span>
   <span class="font10">there </span>
   <span class="font10">well </span>
   <span class="font10">when </span>
   <span class="font10">Infect </span>
   <span class="font10">Rev </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">bond </span>
   <span class="font10">evaluation </span>
   <span class="font10">fight </span>
   <span class="font10">given </span>
   <span class="font10">investigation </span>
   <span class="font10">mortality </span>
   <span class="font10">â€" </span>
   <span class="font10">Antimicrob </span>
   <span class="font10">Arbidol </span>
   <span class="font10">Clin </span>
   <span class="font10">cells. </span>
   <span class="font10">cellular </span>
   <span class="font10">considered </span>
   <span class="font10">could </span>
   <span class="font10">effective </span>
   <span class="font10">hepatitis </span>
   <span class="font10">high </span>
   <span class="font10">infections </span>
   <span class="font10">plasma </span>
   <span class="font10">ring </span>
   <span class="font10">same </span>
   <span class="font10">structural </span>
   <span class="font10">symptoms </span>
   <span class="font10">tests </span>
   <span class="font10">vaccines </span>
   <span class="font10">viruses </span>
   <span class="font10">-position </span>
   <span class="font10">Chem </span>
   <span class="font10">DNA </span>
   <span class="font10">NTZ </span>
   <span class="font10">concentrations </span>
   <span class="font10">discovery </span>
   <span class="font10">displayed </span>
   <span class="font10">either </span>
   <span class="font10">even </span>
   <span class="font10">fusion </span>
   <span class="font10">genome </span>
   <span class="font10">group </span>
   <span class="font10">investigated </span>
   <span class="font10">likely </span>
   <span class="font10">low </span>
   <span class="font10">once </span>
   <span class="font10">prevent </span>
   <span class="font10">reported </span>
   <span class="font10">review </span>
   <span class="font10">suggest </span>
   <span class="font10">thus </span>
   <span class="font10">via </span>
   <span class="font10">(), </span>
   <span class="font10">Agents </span>
   <span class="font10">Among </span>
   <span class="font10">HIV- </span>
   <span class="font10">Hence, </span>
   <span class="font10">However, </span>
   <span class="font10">RdRp </span>
   <span class="font10">addition, </span>
   <span class="font10">affinity </span>
   <span class="font10">analogue </span>
   <span class="font10">available </span>
   <span class="font10">because </span>
   <span class="font10">dose </span>
   <span class="font10">essential </span>
   <span class="font10">indicate </span>
   <span class="font10">indicated </span>
   <span class="font10">indole </span>
   <span class="font10">inhibitory </span>
   <span class="font10">interactions </span>
   <span class="font10">oral </span>
   <span class="font10">order </span>
   <span class="font10">outcomes </span>
   <span class="font10">present </span>
   <span class="font10">rate </span>
   <span class="font10">they </span>
   <span class="font10">treated </span>
   <span class="font10">useful </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">Nsp, </span>
   <span class="font10">better </span>
   <span class="font10">complex </span>
   <span class="font10">compounds </span>
   <span class="font10">control </span>
   <span class="font10">convalescent </span>
   <span class="font10">doses </span>
   <span class="font10">during </span>
   <span class="font10">evaluated </span>
   <span class="font10">identified </span>
   <span class="font10">in-vivo </span>
   <span class="font10">inhibited </span>
   <span class="font10">main </span>
   <span class="font10">most </span>
   <span class="font10">nuclear </span>
   <span class="font10">pneumonia </span>
   <span class="font10">potent </span>
   <span class="font10">presented </span>
   <span class="font10">replication. </span>
   <span class="font10">research </span>
   <span class="font10">role </span>
   <span class="font10">similar </span>
   <span class="font10">small </span>
   <span class="font10">still </span>
   <span class="font10">time </span>
   <span class="font10">using </span>
   <span class="font10">vaccine </span>
   <span class="font10">verified </span>
   <span class="font10">virus, </span>
   <span class="font10">without </span>
   <span class="font10">Baricitinib </span>
   <span class="font10">CoVs </span>
   <span class="font10">CsA </span>
   <span class="font10">Dasabuvir </span>
   <span class="font10">LPV/RTV </span>
   <span class="font10">Results </span>
   <span class="font10">Sci </span>
   <span class="font10">There </span>
   <span class="font10">They </span>
   <span class="font10">already </span>
   <span class="font10">alternative </span>
   <span class="font10">assay </span>
   <span class="font10">based </span>
   <span class="font10">best </span>
   <span class="font10">chronic </span>
   <span class="font10">cytokine </span>
   <span class="font10">darunavir </span>
   <span class="font10">developed </span>
   <span class="font10">extreme </span>
   <span class="font10">formation </span>
   <span class="font10">good </span>
   <span class="font10">identify </span>
   <span class="font10">imatinib </span>
   <span class="font10">infection, </span>
   <span class="font10">influenza </span>
   <span class="font10">like </span>
   <span class="font10">mechanisms </span>
   <span class="font10">nucleoside </span>
   <span class="font10">nucleotide </span>
   <span class="font10">only </span>
   <span class="font10">oseltamivir </span>
   <span class="font10">pharmacological </span>
   <span class="font10">process </span>
   <span class="font10">randomized </span>
   <span class="font10">residues </span>
   <span class="font10">shown </span>
   <span class="font10">significant </span>
   <span class="font10">specific </span>
   <span class="font10">systematic </span>
   <span class="font10">targeting </span>
   <span class="font10">trial </span>
   <span class="font10">virus. </span>
   <span class="font10">Based </span>
   <span class="font10">COVID-, </span>
   <span class="font10">FPV </span>
   <span class="font10">IMP </span>
   <span class="font10">One </span>
   <span class="font10">PLpro </span>
   <span class="font10">RBD </span>
   <span class="font10">SARS </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">acid </span>
   <span class="font10">act </span>
   <span class="font10">addition </span>
   <span class="font10">assays </span>
   <span class="font10">atazanavir </span>
   <span class="font10">bases </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">captopril </span>
   <span class="font10">caused </span>
   <span class="font10">concentration </span>
   <span class="font10">confirmed </span>
   <span class="font10">day </span>
   <span class="font10">disease. </span>
   <span class="font10">drugs. </span>
   <span class="font10">elevated </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">growth </span>
   <span class="font10">hydrogen </span>
   <span class="font10">infection. </span>
   <span class="font10">infections. </span>
   <span class="font10">known </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">management </span>
   <span class="font10">model </span>
   <span class="font10">molecule </span>
   <span class="font10">molecules </span>
   <span class="font10">natural </span>
   <span class="font10">out </span>
   <span class="font10">plus </span>
   <span class="font10">positive </span>
   <span class="font10">presents </span>
   <span class="font10">proteins. </span>
   <span class="font10">relation </span>
   <span class="font10">risk </span>
   <span class="font10">strong </span>
   <span class="font10">transmission </span>
   <span class="font10">treatments </span>
   <span class="font10">tyrosine </span>
   <span class="font10">under </span>
   <span class="font10">â€¯days </span>
   <span class="font10">After </span>
   <span class="font10">DSF </span>
   <span class="font10">Data </span>
   <span class="font10">Dis </span>
   <span class="font10">Discov </span>
   <span class="font10">Drug </span>
   <span class="font10">Ebola </span>
   <span class="font10">Fig. </span>
   <span class="font10">Its </span>
   <span class="font10">Microbiol </span>
   <span class="font10">Nsp </span>
   <span class="font10">Regarding </span>
   <span class="font10">TFV </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">among </span>
   <span class="font10">analogues </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">antibodies </span>
   <span class="font10">before </span>
   <span class="font10">confirm </span>
   <span class="font10">current </span>
   <span class="font10">cycle </span>
   <span class="font10">disease, </span>
   <span class="font10">domain </span>
   <span class="font10">evidence </span>
   <span class="font10">further </span>
   <span class="font10">had </span>
   <span class="font10">highlight </span>
   <span class="font10">inflammatory </span>
   <span class="font10">information </span>
   <span class="font10">interaction </span>
   <span class="font10">interferon </span>
   <span class="font10">intracellular </span>
   <span class="font10">life </span>
   <span class="font10">membrane </span>
   <span class="font10">nitrogenous </span>
   <span class="font10">number </span>
   <span class="font10">patients. </span>
   <span class="font10">pointed </span>
   <span class="font10">polymerase </span>
   <span class="font10">prevents </span>
   <span class="font10">production </span>
   <span class="font10">purine </span>
   <span class="font10">px; </span>
   <span class="font10">recent </span>
   <span class="font10">reduced </span>
   <span class="font10">scientific </span>
   <span class="font10">show </span>
   <span class="font10">site </span>
   <span class="font10">spite </span>
   <span class="font10">strategies </span>
   <span class="font10">values </span>
   <span class="font10">who </span>
   <span class="font10">will </span>
   <span class="font10">{font-family </span>
   <span class="font10">(). </span>
   <span class="font10">CLpro. </span>
   <span class="font10">Chemical </span>
   <span class="font10">CoV </span>
   <span class="font10">GCV </span>
   <span class="font10">GSV </span>
   <span class="font10">HCoVs </span>
   <span class="font10">IL- </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">MLT </span>
   <span class="font10">Med./NEJMoa </span>
   <span class="font10">Middle </span>
   <span class="font10">absence </span>
   <span class="font10">achieved </span>
   <span class="font10">activity. </span>
   <span class="font10">ahead </span>
   <span class="font10">amino </span>
   <span class="font10">analysis </span>
   <span class="font10">animal </span>
   <span class="font10">any </span>
   <span class="font10">associated </span>
   <span class="font10">become </span>
   <span class="font10">binds </span>
   <span class="font10">blood </span>
   <span class="font10">cancer </span>
   <span class="font10">candidate </span>
   <span class="font10">candidates </span>
   <span class="font10">cases </span>
   <span class="font10">chemical </span>
   <span class="font10">compound </span>
   <span class="font10">cysteine </span>
   <span class="font10">demonstrated </span>
   <span class="font10">derivatives, </span>
   <span class="font10">develop </span>
   <span class="font10">drugs, </span>
   <span class="font10">expression </span>
   <span class="font10">far </span>
   <span class="font10">fever </span>
   <span class="font10">font-size </span>
   <span class="font10">ganciclovir </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">highly </span>
   <span class="font10">increase </span>
   <span class="font10">lead </span>
   <span class="font10">lung </span>
   <span class="font10">may </span>
   <span class="font10">means </span>
   <span class="font10">monotherapy </span>
   <span class="font10">need </span>
   <span class="font10">nelfinavir </span>
   <span class="font10">noteworthy </span>
   <span class="font10">nucleocapsid </span>
   <span class="font10">oxygen </span>
   <span class="font10">pathogenic </span>
   <span class="font10">patient </span>
   <span class="font10">preclinical </span>
   <span class="font10">pulmonary </span>
   <span class="font10">regarding </span>
   <span class="font10">release </span>
   <span class="font10">relevant </span>
   <span class="font10">report </span>
   <span class="font10">repurposed </span>
   <span class="font10">responsible </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">stages </span>
   <span class="font10">transcription </span>
   <span class="font10">treatment, </span>
   <span class="font10">treatment. </span>
   <span class="font10">trials. </span>
   <span class="font10">value </span>
   <span class="font10">various </span>
   <span class="font10">vitro </span>
   <span class="font10">whether </span>
   <span class="font10">whose </span>
   <span class="font10">&amp;amp; </span>
   <span class="font10">(Kd </span>
   <span class="font10">(PDB </span>
   <span class="font10">Clinical </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Darunavir </span>
   <span class="font10">East </span>
   <span class="font10">FDA </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">GS- </span>
   <span class="font10">HIV </span>
   <span class="font10">Health </span>
   <span class="font10">IL-, </span>
   <span class="font10">June </span>
   <span class="font10">Mpro </span>
   <span class="font10">Nelfinavir </span>
   <span class="font10">RECOVERY </span>
   <span class="font10">SBV </span>
   <span class="font10">Tenofovir </span>
   <span class="font10">Vero </span>
   <span class="font10">Virol </span>
   <span class="font10">about </span>
   <span class="font10">according </span>
   <span class="font10">activation </span>
   <span class="font10">activities </span>
   <span class="font10">adenosine </span>
   <span class="font10">alternatives </span>
   <span class="font10">and, </span>
   <span class="font10">article </span>
   <span class="font10">bind </span>
   <span class="font10">blocking </span>
   <span class="font10">called </span>
   <span class="font10">characteristics </span>
   <span class="font10">clinically </span>
   <span class="font10">cohort </span>
   <span class="font10">concluded </span>
   <span class="font10">death </span>
   <span class="font10">derivative </span>
   <span class="font10">described </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">efficient </span>
   <span class="font10">enzymes </span>
   <span class="font10">enzymes, </span>
   <span class="font10">evidences </span>
   <span class="font10">fast </span>
   <span class="font10">focused </span>
   <span class="font10">found </span>
   <span class="font10">free </span>
   <span class="font10">function </span>
   <span class="font10">great </span>
   <span class="font10">hand, </span>
   <span class="font10">helicase </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">identification </span>
   <span class="font10">importance </span>
   <span class="font10">individuals </span>
   <span class="font10">infectious </span>
   <span class="font10">innate </span>
   <span class="font10">last </span>
   <span class="font10">latter </span>
   <span class="font10">levels </span>
   <span class="font10">line </span>
   <span class="font10">many </span>
   <span class="font10">might </span>
   <span class="font10">non-structural </span>
   <span class="font10">obtained </span>
   <span class="font10">ongoing </span>
   <span class="font10">outbreak </span>
   <span class="font10">pandemic </span>
   <span class="font10">pandemic, </span>
   <span class="font10">part </span>
   <span class="font10">patients, </span>
   <span class="font10">print] </span>
   <span class="font10">properties </span>
   <span class="font10">proteinase </span>
   <span class="font10">published </span>
   <span class="font10">receptor-binding </span>
   <span class="font10">reduce </span>
   <span class="font10">reports </span>
   <span class="font10">requires </span>
   <span class="font10">respectively. </span>
   <span class="font10">safe </span>
   <span class="font10">since </span>
   <span class="font10">single </span>
   <span class="font10">spread </span>
   <span class="font10">support </span>
   <span class="font10">system </span>
   <span class="font10">tested </span>
   <span class="font10">therapies </span>
   <span class="font10">therapy, </span>
   <span class="font10">therapy. </span>
   <span class="font10">translated </span>
   <span class="font10">transport </span>
   <span class="font10">whereas </span>
   <span class="font10">Î±/Î² </span>
   <span class="font10">â€¯mg </span>
   <span class="font10">-FU </span>
   <span class="font10">-position, </span>
   <span class="font10">.â€¯ÂµM </span>
   <span class="font10">Accessed </span>
   <span class="font10">Another </span>
   <span class="font10">Biophys </span>
   <span class="font10">COVID-J </span>
   <span class="font10">Chem./j.bmc... </span>
   <span class="font10">Chemother </span>
   <span class="font10">Chemother./AAC.- </span>
   <span class="font10">China </span>
   <span class="font10">CoVs, </span>
   <span class="font10">Despite </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">HCQ, </span>
   <span class="font10">IFN-Î±b </span>
   <span class="font10">Immunol </span>
   <span class="font10">New </span>
   <span class="font10">Next, </span>
   <span class="font10">Nonetheless, </span>
   <span class="font10">Notwithstanding, </span>
   <span class="font10">PLpro, </span>
   <span class="font10">Research </span>
   <span class="font10">Sayad </span>
   <span class="font10">Since </span>
   <span class="font10">Some </span>
   <span class="font10">Such </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">Thus, </span>
   <span class="font10">Virol./JVI.- </span>
   <span class="font10">action, </span>
   <span class="font10">activated </span>
   <span class="font10">activity, </span>
   <span class="font10">administered </span>
   <span class="font10">affected </span>
   <span class="font10">agent </span>
   <span class="font10">allows </span>
   <span class="font10">analysed </span>
   <span class="font10">animals </span>
   <span class="font10">availability </span>
   <span class="font10">basis </span>
   <span class="font10">blocks </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cancer, </span>
   <span class="font10">capable </span>
   <span class="font10">case </span>
   <span class="font10">cause </span>
   <span class="font10">cells, </span>
   <span class="font10">chloroquine </span>
   <span class="font10">claim </span>
   <span class="font10">class </span>
   <span class="font10">complex, </span>
   <span class="font10">complex. </span>
   <span class="font10">complications </span>
   <span class="font10">coronavirus. </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">countries </span>
   <span class="font10">did </span>
   <span class="font10">diseases, </span>
   <span class="font10">drug, </span>
   <span class="font10">drugs: </span>
   <span class="font10">emetine </span>
   <span class="font10">experimental </span>
   <span class="font10">factors </span>
   <span class="font10">features </span>
   <span class="font10">future </span>
   <span class="font10">global </span>
   <span class="font10">group. </span>
   <span class="font10">groups </span>
   <span class="font10">guanine </span>
   <span class="font10">healthy </span>
   <span class="font10">hepatic </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">importin </span>
   <span class="font10">improvement </span>
   <span class="font10">include </span>
   <span class="font10">increased </span>
   <span class="font10">indication </span>
   <span class="font10">indispensable </span>
   <span class="font10">induced </span>
   <span class="font10">induces </span>
   <span class="font10">infections, </span>
   <span class="font10">inferior </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">involved </span>
   <span class="font10">key </span>
   <span class="font10">lack </span>
   <span class="font10">ligands </span>
   <span class="font10">literature </span>
   <span class="font10">load </span>
   <span class="font10">makes </span>
   <span class="font10">medicinal </span>
   <span class="font10">medicine </span>
   <span class="font10">metabolite </span>
   <span class="font10">modelling </span>
   <span class="font10">monoclonal </span>
   <span class="font10">multiple </span>
   <span class="font10">options </span>
   <span class="font10">oseltamivir. </span>
   <span class="font10">outcome </span>
   <span class="font10">pandemic. </span>
   <span class="font10">people </span>
   <span class="font10">performed </span>
   <span class="font10">point </span>
   <span class="font10">polyproteins </span>
   <span class="font10">preventing </span>
   <span class="font10">probably </span>
   <span class="font10">prompted </span>
   <span class="font10">prophylactic </span>
   <span class="font10">range </span>
   <span class="font10">receptors </span>
   <span class="font10">reduces </span>
   <span class="font10">reducing </span>
   <span class="font10">reduction </span>
   <span class="font10">researchers </span>
   <span class="font10">resource </span>
   <span class="font10">response </span>
   <span class="font10">results, </span>
   <span class="font10">revealed </span>
   <span class="font10">samples </span>
   <span class="font10">screening </span>
   <span class="font10">search </span>
   <span class="font10">similarity </span>
   <span class="font10">solid; </span>
   <span class="font10">spectrum </span>
   <span class="font10">stage </span>
   <span class="font10">strand </span>
   <span class="font10">study, </span>
   <span class="font10">subunit </span>
   <span class="font10">sufficient </span>
   <span class="font10">synthesis, </span>
   <span class="font10">targets. </span>
   <span class="font10">that, </span>
   <span class="font10">thereby </span>
   <span class="font10">three </span>
   <span class="font10">times </span>
   <span class="font10">valganciclovir </span>
   <span class="font10">virtual </span>
   <span class="font10">viruses, </span>
   <span class="font10">widely </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€¯years </span>
   <span class="font10">â€² </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">(S) </span>
   <span class="font10">(SARS-CoV-) </span>
   <span class="font10">,â€¯nM), </span>
   <span class="font10">-position. </span>
   <span class="font10">.â€¯Î¼M </span>
   <span class="font10">ACE, </span>
   <span class="font10">Acad </span>
   <span class="font10">Agents./j.ijantimicag.. </span>
   <span class="font10">Because </span>
   <span class="font10">Biol </span>
   <span class="font10">Both </span>
   <span class="font10">CQ, </span>
   <span class="font10">Captopril </span>
   <span class="font10">Chem./j.ejmech... </span>
   <span class="font10">Chinese </span>
   <span class="font10">Covid-N </span>
   <span class="font10">DrugBank </span>
   <span class="font10">For </span>
   <span class="font10">Gen </span>
   <span class="font10">HCoVs, </span>
   <span class="font10">LPV/RTV. </span>
   <span class="font10">Lett./j.bmcl... </span>
   <span class="font10">MERS-CoV. </span>
   <span class="font10">More </span>
   <span class="font10">Mpro. </span>
   <span class="font10">ORFa </span>
   <span class="font10">Pharm </span>
   <span class="font10">Pharmacol </span>
   <span class="font10">Protein </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">RdRp, </span>
   <span class="font10">Recent </span>
   <span class="font10">Recently, </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Res./j.antiviral... </span>
   <span class="font10">Respir </span>
   <span class="font10">Several </span>
   <span class="font10">Sofosbuvir </span>
   <span class="font10">Struct </span>
   <span class="font10">Telbivudine </span>
   <span class="font10">Trials </span>
   <span class="font10">Using </span>
   <span class="font10">Valganciclovir </span>
   <span class="font10">Virus </span>
   <span class="font10">Zika </span>
   <span class="font10">able </span>
   <span class="font10">activities, </span>
   <span class="font10">adenine </span>
   <span class="font10">adult </span>
   <span class="font10">agents </span>
   <span class="font10">al., </span>
   <span class="font10">alcohol </span>
   <span class="font10">allowed </span>
   <span class="font10">allowing </span>
   <span class="font10">another </span>
   <span class="font10">anti-coronavirus </span>
   <span class="font10">antibody </span>
   <span class="font10">anticancer </span>
   <span class="font10">antiparasitic </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">antitumor </span>
   <span class="font10">aromatic </span>
   <span class="font10">arthritis </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">beginning </span>
   <span class="font10">beneficial </span>
   <span class="font10">benzene </span>
   <span class="font10">blocked </span>
   <span class="font10">bold </span>
   <span class="font10">broad </span>
   <span class="font10">capacity </span>
   <span class="font10">catalytic </span>
   <span class="font10">causing </span>
   <span class="font10">centre </span>
   <span class="font10">clear </span>
   <span class="font10">cleavage </span>
   <span class="font10">coded </span>
   <span class="font10">common </span>
   <span class="font10">compared </span>
   <span class="font10">complete </span>
   <span class="font10">controlled </span>
   <span class="font10">coronavirus, </span>
   <span class="font10">courier; </span>
   <span class="font10">cytosine </span>
   <span class="font10">database </span>
   <span class="font10">decrease </span>
   <span class="font10">demands </span>
   <span class="font10">dengue </span>
   <span class="font10">developing </span>
   <span class="font10">diabetes </span>
   <span class="font10">direct </span>
   <span class="font10">diseases </span>
   <span class="font10">distress </span>
   <span class="font10">drug. </span>
   <span class="font10">duration </span>
   <span class="font10">each </span>
   <span class="font10">effectiveness </span>
   <span class="font10">effects, </span>
   <span class="font10">em; </span>
   <span class="font10">employed </span>
   <span class="font10">envelope </span>
   <span class="font10">established </span>
   <span class="font10">evolution </span>
   <span class="font10">existence </span>
   <span class="font10">expected </span>
   <span class="font10">fact </span>
   <span class="font10">find </span>
   <span class="font10">followed </span>
   <span class="font10">functional </span>
   <span class="font10">gemcitabine </span>
   <span class="font10">genes </span>
   <span class="font10">genetic </span>
   <span class="font10">genomics </span>
   <span class="font10">glycoproteins </span>
   <span class="font10">helicase, </span>
   <span class="font10">heterocyclic </span>
   <span class="font10">hypothesis </span>
   <span class="font10">immunity </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">improve </span>
   <span class="font10">increases </span>
   <span class="font10">induce </span>
   <span class="font10">infection: </span>
   <span class="font10">inhibitor. </span>
   <span class="font10">interferes </span>
   <span class="font10">interfering </span>
   <span class="font10">isolated </span>
   <span class="font10">kinase, </span>
   <span class="font10">knowledge </span>
   <span class="font10">large </span>
   <span class="font10">largely </span>
   <span class="font10">limitations </span>
   <span class="font10">little </span>
   <span class="font10">lopinavir </span>
   <span class="font10">macrophages </span>
   <span class="font10">mainly </span>
   <span class="font10">marketed </span>
   <span class="font10">medication </span>
   <span class="font10">melatonin </span>
   <span class="font10">moderate </span>
   <span class="font10">monitoring </span>
   <span class="font10">mouse </span>
   <span class="font10">myeloid </span>
   <span class="font10">nAbs </span>
   <span class="font10">negative </span>
   <span class="font10">neutralizing </span>
   <span class="font10">noted </span>
   <span class="font10">nucleus </span>
   <span class="font10">often </span>
   <span class="font10">option </span>
   <span class="font10">organs </span>
   <span class="font10">over </span>
   <span class="font10">pathophysiology </span>
   <span class="font10">powerful </span>
   <span class="font10">presence </span>
   <span class="font10">pro-inflammatory </span>
   <span class="font10">prodrug </span>
   <span class="font10">produce </span>
   <span class="font10">produced </span>
   <span class="font10">proteins, </span>
   <span class="font10">provided </span>
   <span class="font10">pt;} </span>
   <span class="font10">randomized, </span>
   <span class="font10">rapidly </span>
   <span class="font10">received </span>
   <span class="font10">recently, </span>
   <span class="font10">regard, </span>
   <span class="font10">released </span>
   <span class="font10">relevance </span>
   <span class="font10">replication, </span>
   <span class="font10">replication., </span>
   <span class="font10">required </span>
   <span class="font10">resistance </span>
   <span class="font10">result </span>
   <span class="font10">risks </span>
   <span class="font10">ritonavir </span>
   <span class="font10">robust </span>
   <span class="font10">second </span>
   <span class="font10">selective </span>
   <span class="font10">series </span>
   <span class="font10">serine </span>
   <span class="font10">severity </span>
   <span class="font10">side </span>
   <span class="font10">six </span>
   <span class="font10">size </span>
   <span class="font10">sofosbuvir </span>
   <span class="font10">stable </span>
   <span class="font10">starts </span>
   <span class="font10">successful </span>
   <span class="font10">superior </span>
   <span class="font10">surface </span>
   <span class="font10">susceptible </span>
   <span class="font10">symptoms. </span>
   <span class="font10">testing </span>
   <span class="font10">then, </span>
   <span class="font10">those </span>
   <span class="font10">triage </span>
   <span class="font10">trials, </span>
   <span class="font10">triphosphate </span>
   <span class="font10">type </span>
   <span class="font10">types </span>
   <span class="font10">understand </span>
   <span class="font10">understanding </span>
   <span class="font10">update </span>
   <span class="font10">uracil </span>
   <span class="font10">vascular </span>
   <span class="font10">virions </span>
   <span class="font10">well-established </span>
   <span class="font10">while </span>
   <span class="font10">would </span>
   <span class="font10">â€¯days. </span>
   <span class="font10">â€¯h. </span>
   <span class="font10">â€¯Î¼M. </span>
  </p>
 </body>
</html>
